Pacira Short Term Debt from 2010 to 2024

PCRX Stock  USD 16.64  0.14  0.83%   
Pacira BioSciences, Short Term Debt yearly trend continues to be fairly stable with very little volatility. Short Term Debt will likely drop to about 16.6 M in 2024. During the period from 2010 to 2024, Pacira BioSciences, Short Term Debt regression line of annual values had r-squared of  0.05 and arithmetic mean of  71,178,193. View All Fundamentals
 
Short Term Debt  
First Reported
2009-12-31
Previous Quarter
18.3 M
Current Value
210.7 M
Quarterly Volatility
73.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pacira BioSciences, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pacira BioSciences,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 79.4 M, Interest Expense of 15.8 M or Selling General Administrative of 63.1 M, as well as many indicators such as Price To Sales Ratio of 2.19, Dividend Yield of 0.0014 or PTB Ratio of 1.7. Pacira financial statements analysis is a perfect complement when working with Pacira BioSciences, Valuation or Volatility modules.
  
Check out the analysis of Pacira BioSciences, Correlation against competitors.
For more information on how to buy Pacira Stock please use our How to Invest in Pacira BioSciences, guide.

Latest Pacira BioSciences,'s Short Term Debt Growth Pattern

Below is the plot of the Short Term Debt of Pacira BioSciences, over the last few years. It is Pacira BioSciences,'s Short Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pacira BioSciences,'s overall financial position and show how it may be relating to other accounts over time.
Short Term Debt10 Years Trend
Pretty Stable
   Short Term Debt   
       Timeline  

Pacira Short Term Debt Regression Statistics

Arithmetic Mean71,178,193
Geometric Mean18,208,869
Coefficient Of Variation141.48
Mean Deviation70,576,245
Median17,442,000
Standard Deviation100,705,854
Sample Variance10141.7T
Range382.3M
R-Value0.21
Mean Square Error10417T
R-Squared0.05
Significance0.44
Slope4,841,090
Total Sum of Squares141983.4T

Pacira Short Term Debt History

202416.6 M
202317.4 M
202251.9 M
2021382.6 M
2020157.1 M
20194.9 M
2018338 K

About Pacira BioSciences, Financial Statements

Pacira BioSciences, investors use historical fundamental indicators, such as Pacira BioSciences,'s Short Term Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pacira BioSciences,. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short Term Debt17.4 M16.6 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Pacira Stock Analysis

When running Pacira BioSciences,'s price analysis, check to measure Pacira BioSciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pacira BioSciences, is operating at the current time. Most of Pacira BioSciences,'s value examination focuses on studying past and present price action to predict the probability of Pacira BioSciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pacira BioSciences,'s price. Additionally, you may evaluate how the addition of Pacira BioSciences, to your portfolios can decrease your overall portfolio volatility.